• Avita Medical held its annual shareholder meeting on June 3, 2026.
• Shareholders ratified Grant Thornton LLP as independent registered public accounting firm for the year ending Dec. 31, 2026.
• Shareholders authorized raising the non-executive directors’ aggregate annual cash fee pool to a maximum of USD 900,000.
• Shareholders authorized annual equity grants for non-executive directors, consisting of restricted stock units and stock options.
• Shareholders authorized initial equity grants to Dr. Michael Tarnoff and Joseph Woody, consisting of restricted stock units and stock options.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avita Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001762303-26-000003), on June 04, 2026, and is solely responsible for the information contained therein.